Pridopidine
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Pridopidine
- DrugBank Accession Number
- DB11947
- Background
Pridopidine has been used in trials studying the treatment of Huntington's Disease.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 281.41
Monoisotopic: 281.144950159 - Chemical Formula
- C15H23NO2S
- Synonyms
- Pridopidine
- External IDs
- ACR16
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Pridopidine Hydrochloride QH6KD74EGF 882737-42-0 YGRHOYQMBLLGEV-UHFFFAOYSA-N
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenylpiperidines. These are compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Piperidines
- Sub Class
- Phenylpiperidines
- Direct Parent
- Phenylpiperidines
- Alternative Parents
- Benzenesulfonyl compounds / Aralkylamines / Sulfones / Trialkylamines / Azacyclic compounds / Organic oxides / Hydrocarbon derivatives
- Substituents
- Amine / Aralkylamine / Aromatic heteromonocyclic compound / Azacycle / Benzenesulfonyl group / Benzenoid / Hydrocarbon derivative / Monocyclic benzene moiety / Organic nitrogen compound / Organic oxide
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- HD4TW8S2VK
- CAS number
- 346688-38-8
- InChI Key
- YGKUEOZJFIXDGI-UHFFFAOYSA-N
- InChI
- InChI=1S/C15H23NO2S/c1-3-9-16-10-7-13(8-11-16)14-5-4-6-15(12-14)19(2,17)18/h4-6,12-13H,3,7-11H2,1-2H3
- IUPAC Name
- 4-(3-methanesulfonylphenyl)-1-propylpiperidine
- SMILES
- CCCN1CCC(CC1)C1=CC=CC(=C1)S(C)(=O)=O
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0256771
- PubChem Compound
- 9795739
- PubChem Substance
- 347828273
- ChemSpider
- 7971505
- BindingDB
- 50308028
- ChEMBL
- CHEMBL596802
- ZINC
- ZINC000022063703
- PharmGKB
- PA166115441
- Wikipedia
- Pridopidine
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Active Not Recruiting Treatment Huntington's Disease (HD) 1 3 Completed Treatment Huntington's Disease (HD) 1 2 Completed Treatment Huntington's Disease (HD) 3 2 Terminated Treatment Huntington's Disease (HD) 1 2 Terminated Treatment Parkinson's Disease (PD) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.045 mg/mL ALOGPS logP 2.55 ALOGPS logP 2.18 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 19.7 Chemaxon pKa (Strongest Basic) 8.03 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 37.38 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 80.05 m3·mol-1 Chemaxon Polarizability 32.23 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0v4j-4960000000-39542056ea95c3024c6c Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-001i-0090000000-d25ac46385a7ba714198 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-0090000000-2c66ed3420a8f38ce3d4 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-0190000000-ff1552184375080c648e Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-0090000000-de4a6664edb7a5603aec Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-004r-6090000000-57377cb5bc6f04f78841 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0005-3920000000-0a3642293ef90896176c Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 176.7222579 predictedDarkChem Lite v0.1.0 [M-H]- 162.95738 predictedDeepCCS 1.0 (2019) [M+H]+ 177.0114579 predictedDarkChem Lite v0.1.0 [M+H]+ 165.31541 predictedDeepCCS 1.0 (2019) [M+Na]+ 177.1653579 predictedDarkChem Lite v0.1.0 [M+Na]+ 171.40868 predictedDeepCCS 1.0 (2019)
Drug created at October 20, 2016 21:03 / Updated at December 13, 2022 10:46